Skip to main content
. 2025 Jan 1;22(2):383–397. doi: 10.7150/ijms.99958

Table 1.

Baseline and demographic characteristics

Mean ± SD P value (vs. placebo) 95% CI (vs. placebo)
Age (years)
Placebo 51.88 ± 8.28 -
LN18178 54.02 ± 8.69 0.1710 -0.93, 5.21
Race (Gender)
Placebo 60 Asian (male) - -
LN18178 60 Asian (male) - -
Height (cm)
Placebo 163.42 ± 4.06 -
LN18178 163.72 ± 5.36 0.7304 -1.42, 2.02
Weight (Kg)
Placebo 66.20 ± 4.61 -
LN18178 66.02 ± 4.77 0.8353 -1.52, 1.88
BMI (kg/m2)
Placebo 24.78 ± 1.38 -
LN18178 24.63 ± 1.27 0.5210 -0.33, 0.63
Total Testosterone (ng/dL)
Placebo 418.52 ± 40.76 -
LN18178 433.40 ± 43.56 0.0557 -0.37, 30.14
Fasting blood glucose (mg/dL)
Placebo 87.65 ± 6.16 - -
LN18178 87.60 ± 7.08 0.9672 -2.35, 2.45
Smoking history (past/present)
Placebo 0 - -
LN18178 0 - -

Values present mean ± standard deviation (SD); placebo (n=60) and LN18178 (n=60). CI: Confidence interval. A P value < 0.05 (independent t-test) was considered significant.